Basis: Current FMP quote-based enterprise value / matching reported total assets. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Assets ratio is 1.94x as of 2026-10-06T16:57:53.409Z.
Calculation as of: 2026-10-06T16:57:53.409Z.
Quote observation: 2026-10-06T16:55:12.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 66afd7ad6fe085f612ae866be6517f9e897c4fba6e73e474a8e5d595bf17d99d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/ASSETS RATIO
1.94x
SECTOR MEDIAN · HEALTHCARE
1.56x
median of 709 covered companies
CURRENT VS SECTOR MEDIAN
+24.36%
vs the sector median at left
Parabilis Medicines, Inc.
Market Cap
$3.32B
EV/Assets Ratio
1.94x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.39B
EV/Assets Ratio
1.77x
TTM Avg
2.64x
3Y Avg
3.32x
5Y Avg
3.97x
Market Cap
$3.41B
EV/Assets Ratio
28.70x
TTM Avg
16.44x
3Y Avg
12.51x
5Y Avg
8.61x
Market Cap
$3.48B
EV/Assets Ratio
2.60x
TTM Avg
4.37x
3Y Avg
3.78x
5Y Avg
3.54x
Market Cap
$3.49B
EV/Assets Ratio
2.48x
TTM Avg
2.50x
3Y Avg
2.57x
5Y Avg
2.24x
Market Cap
$3.55B
EV/Assets Ratio
3.68x
TTM Avg
4.92x
3Y Avg
4.96x
5Y Avg
6.14x
Market Cap
$3.09B
EV/Assets Ratio
2.52x
TTM Avg
3.01x
3Y Avg
2.48x
5Y Avg
2.60x
| NAME | MARKET CAP | EV/ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Parabilis Medicines, Inc. (PBLS) | $3.32B | 1.94x | N/A | N/A | N/A |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.39B | 1.77x | 2.64x | 3.32x | 3.97x |
| CareDx, Inc (CDNA)vs › | $3.40B | 5.71x | 2.86x | 2.13x | 2.05x |
| Pulse Biosciences, Inc. (PLSE)vs › | $3.41B | 28.70x | 16.44x | 12.51x | 8.61x |
| Xenon Pharmaceuticals Inc. (XENE)vs › | $3.48B | 2.60x | 4.37x | 3.78x | 3.54x |
| Celcuity Inc. (CELC)vs › | $3.49B | 4.91x | 11.74x | 6.13x | 4.25x |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.49B | 2.48x | 2.50x | 2.57x | 2.24x |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.55B | 3.68x | 4.92x | 4.96x | 6.14x |
| Denali Therapeutics Inc. (DNLI)vs › | $3.09B | 2.52x | 3.01x | 2.48x | 2.60x |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $3.04B | 6.39x | 8.14x | 4.99x | 3.94x |
EV/Assets compares enterprise value to total assets. It is useful for asset-heavy businesses and for comparing how much the market pays for each dollar of assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
